Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 555, 428-430 (2018)
doi: https://doi.org/10.1038/d41586-018-03268-4
Updates & Corrections
-
Correction 26 April 2018: An earlier version of this story incorrectly stated that ViaCyte had restarted a 2014 clinical trial after redesigning its encapsulation technology.
References
Sagi, I. et al. Nature 532, 107–111 (2016).
da Cruz, L. et al. Nature Biotechnol. http://dx.doi.org/10.1038/nbt.4114 (2018).
Martin, G. R. Proc. Natl Acad. Sci. USA 78, 7634–7638 (1981).
Evans, M. J. & Kaufman, M. H. Nature 292, 154–156 (1981).
Thomson, J. A. et al. Proc. Natl Acad. Sci. USA 92, 7844–7848 (1995).
Thomson, J. A. et al. Science 282, 1145–1147 (1998).
Murray, C. E. & Keller, G. Cell 132, 661–680 (2008).
Tachibana, M. et al. Cell 153, 1228–1238 (2013).
Takahashi, K. & Yamanaka, S. Cell 126, 663–676 (2006).
Takahashi, K. et al. Cell 131, 861–872 (2007).
Yu, J. et al. Science 318, 1917–1920 (2007).
Watanabe, K. et al. Nature Biotechnol. 25, 681–686 (2007).
Verlinksy, Y. et al. Reprod. Biomed. Online 10, 105–110 (2005).
Eiges, R. et al. Cell Stem Cell 1, 568–577 (2007).
Dimos, J. T. et al. Science 321, 1218–1221 (2008).